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Abnormal splicing of LMNA gene or aberrant pro-
cessing of prelamin A results in progeroid syndrome.
Here we show that lamin A interacts with and acti-
vates SIRT1. SIRT1 exhibits reduced association
with nuclear matrix (NM) and decreased deacetylase
activity in the presence of progerin or prelamin
A, leading to rapid depletion of adult stem cells
(ASCs) in Zmpste24/ mice. Resveratrol enhances
the binding between SIRT1 and A-type lamins to
increases its deacetylase activity. Resveratrol treat-
ment rescues ASC decline, slows down body weight
loss, improves trabecular bone structure andmineral
density, and significantly extends the life span in
Zmpste24/ mice. Our data demonstrate lamin A
as an activator of SIRT1 and provide a mechanistic
explanation for the activation of SIRT1 by resveratrol.
The link between conserved SIRT1 longevity path-
way and progeria suggests a stem cell-based and
SIRT1 pathway-dependent therapeutic strategy for
progeria.
INTRODUCTION
Lamin A, encoded by the LMNA locus, is a major component of
the nuclear matrix (NM), a filamentous nucleoskeleton important
for nuclear structure maintenance. Chromatin and other proteins
dynamically associate with the NM to regulate various nuclear
activities, including replication, gene transcription, DNA repair,
and chromatin organization (Tsutsui et al., 2005). NM copurifies
with a majority of the nuclear histone deacetylase (HDAC)
activity, thus regulating chromatin structure (Hendzel et al.,
1991). A de novo G608G mutation in LMNA results in alternative
splicing, giving rise to a truncated prelamin A, termed progerin,738 Cell Metabolism 16, 738–750, December 5, 2012 ª2012 Elsevierwhich is the predominant cause of Hutchinson-Gilford Progeria
Syndrome (HGPS), a severe form of early-onset premature aging
(Eriksson et al., 2003).Mice deficient for Zmpste24, ametallopro-
teinase responsible for prelamin A maturation, manifest many
of the progeroid features resembling HGPS patients (Penda´s
et al., 2002). We and others previously have shown that HGPS
skin fibroblasts and mouse embryonic fibroblasts (MEFs)
derived from Zmpste24/ embryos undergo early senescence,
attributable to genomic instability and hyperactivation of the
p53 pathway, and that reduction of the prelamin A level in
Zmpste24/ mice by Lmna heterozygosity ameliorates proge-
roid phenotypes and significantly extends life span (Liu et al.,
2005; Varela et al., 2005). Human cells engineered to express
progerin exhibited premature senescence (Kudlow et al.,
2008). One of the hallmarks of progeria cells is a misshaped
nucleus, which leads to disorganized heterochromatin (Scaffidi
and Misteli, 2005) and mislocalized nuclear proteins (Krishnan
et al., 2011; Liu et al., 2008; Manju et al., 2006; Scaffidi and
Misteli, 2008). Reducing membrane-bound prelamin A or pro-
gerin by farnesyl transferase inhibitor rescues the nuclear shape
abnormality and ameliorates progeroid features (Fong et al.,
2006; Gordon et al., 2012).
NAD+-dependent protein deacetylase SIRT1, the closest
homolog of Saccharomyces cerevisiae Sir2 (silent information
regulator 2), regulates various metabolic pathways (Haigis and
Sinclair, 2010). Loss of SIRT1 causes defective gametogenesis,
heart and retinal abnormalities, genomic instability, small body
size, and reduced survival in mice (Cheng et al., 2003; McBurney
et al., 2003; Wang et al., 2008) and abolishes many beneficial
effects of dietary restriction (DR) (Chen et al., 2005). Although
life span extension in yeast, worms, and flies by ectopic Sir2 is
under debate (Burnett et al., 2011; Lombard et al., 2011; Viswa-
nathan and Guarente, 2011), transgenic mice with additional
copies of SIRT1 show phenotypes resembling DR (Alcendor
et al., 2007; Banks et al., 2008; Bordone et al., 2007; Herranz
et al., 2010; Pfluger et al., 2008). SIRT1 activator resveratrol in-
creases life span in yeast, worms, and flies and enhances healthInc.
Figure 1. SIRT1 Interacts with Lamin A
(A) FLAG-SIRT1 and lamin A were ectopically ex-
pressed in HEK293 cells. By western blotting,
lamin A was detected in anti-FLAG immunopre-
cipitates; FLAG-SIRT1 was detected in anti-lamin
A/C immunoprecipitates.
(B) In total cell lysates of HEK293 cells, SIRT1 was
pulled down by anti-lamin A/C immunoprecipi-
tates and lamin A was pulled down by anti-SIRT1
immunoprecipitates.
(C) Representative immunofluorescence confocal
microscopy of SIRT1 and lamin A/C in human
fibroblasts. The majority of nuclear SIRT1 coloc-
alizes with lamin A in the nuclear interior (arrows).
Scale bar, 5 mm.
(D) Representative confocal microscopy showing
colocalization of EGFP-SIRT1 and DsRed-lamin A
in human fibroblast cells. Scale bar, 10 mm.
(E) Lamin A but not lamin C was pulled down in
anti-FLAG-SIRT1 immunoprecipitates in HEK293
cells.
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2007; Wood et al., 2004). Though how resveratrol activates
SIRT1 is still unclear (Villalba et al., 2012), many of its in vivo
benefits are dependent on SIRT1 (Baur, 2010). SIRT1 deacety-
lates a variety of proteins and regulates genomic integrity,
inflammatory response, adipogenesis, mitochondrial biogen-
esis, and stress resistance (Lavu et al., 2008). Of note, SIRT1
deacetylates Foxo3a to enhance stress resistance through
MnSOD, catalase, and Gadd45a, etc. (Brunet et al., 2004).
SIRT1 is highly expressed in embryonic stem cells (ESCs), but
is reduced in differentiated cells through a process mediated
by miRNAs (Saunders et al., 2010). SIRT1 is required for mainte-
nance of self-renewal of ESCs via modulating p53 cellular distri-
bution and Nanog expression (Han et al., 2008). The hematopoi-
etic differentiation of ESCs is defective, and the number and
function of hematopoietic progenitor cells decline in SIRT1/
and SIRT1+/ mice (Ou et al., 2011). When cultured under 5%
oxygen, both SIRT1/ and SIRT1+/ hematopoietic progenitor
cells exhibit defective proliferation comparedwith wild-type cells
(Mantel et al., 2008).
Alternate splicing events also occur at the wild-type LMNA
locus (Scaffidi and Misteli, 2006). That the number of cells ex-
pressing progerin increases in normal aged individuals (McClin-
tock et al., 2007) and that telomere shortening or dysfunction
activates progerin production (Cao et al., 2011) raise the possi-
bility that progerin may contribute to normal aging (Burtner and
Kennedy, 2010), possibly through modulating the activity of
longevity/antiaging proteins. Given the essential roles of NM in
preserving HDAC activity and the longevity-promoting proper-Cell Metabolism 16, 738–750,ties of SIRT1, we tested the potential
effect of prelamin A on SIRT1. We found
that lamin A directly interacts with and
serves as an activator of SIRT1 on the
NM; prelamin A and progerin exhibit
significantly reduced binding capacity to
SIRT1 in vivo, leading to a rapid decline
of ASCs in Zmpste24/ mice. Resvera-
trol increases the binding of SIRT1 withA-type lamins and thus enhances its deacetylase activity,
restores ASC population, ameliorates progeroid features, and
extends life span in Zmpste24/ mice.
RESULTS
Lamin A Interacts with SIRT1
To test the potential involvement of SIRT1 in progeria, we first
examined the potential interaction between lamin A and SIRT1
by coimmunoprecipitation in HEK293 cells expressing ectopic
FLAG-SIRT1. As shown in Figure 1A, lamin A was pulled down
in the anti-FLAG immunoprecipitates, while FLAG-SIRT1 was
detected in the anti-lamin A/C immunoprecipitates. The interac-
tion between endogenous SIRT1 and lamin A was confirmed in
HEK293 cells, bone marrow stromal cells (BMSCs), and MEFs,
where anti-SIRT1 immunoprecipitates pulled down lamin A and
vice versa (Figures 1B, S1A, and S1B). Immunofluorescence
confocal microscopy showed that lamin A localizes both on
the nuclear envelope and in the interior nucleoplasm. A signifi-
cant portion of the nuclear SIRT1 colocalized with nucleoplasmic
lamin A in the nuclear interior in human fibroblasts (Figure 1C).
Consistently, ectopic EGFP-SIRT1 and DsRed-lamin A coex-
isted in the nuclear interior (Figure 1D). This interaction seems
specific to nuclear SIRT1, as neither cytoplasmic SIRT2 nor
mitochondrial SIRT5 was detected in the anti-GFP-lamin A
immunoprecipitates (Figure S1C).
Alternative splicing of LMNA gives rise to different A-type lam-
ins, of which lamin A and C are the most abundant (Lin and Wor-
man, 1993). Lamin A and C share the first 566 aa; lamin A hasDecember 5, 2012 ª2012 Elsevier Inc. 739
Figure 2. Lamin A Is an Activator of SIRT1
(A) Recombinant human SIRT1 (rhSIRT1) was
pulled down by anti-lamin A immunoprecipitates in
test tubes containing rhSIRT1 and recombinant
human lamin A (rhLamin A).
(B) RhSIRT1 deacetylase activity was determined
by BioMol SIRT1 Fluorimetric Drug Discovery Kit
(BSDK) in the presence or absence of rhLamin A.
Data represent mean ± SEM, n = 3. *p < 0.05,
**p < 0.01, rhLamin A + rhSIRT1 versus rhSIRT1
only. ***The molar ratios of rhLamin A to rhSIRT1
are 0.5, 1.0, 2.0, and 4.0, respectively.
(C) Acetyl FLAG-p53 was incubated with rhSIRT1
in the presence or absence of rhLamin A. FLAG-
p53 acetylation was detected by western blotting
with anti-acetyl lysine antibodies. Relative level of
acetylated p53 was quantified by ImageJ. *The
molar ratio of rhLamin A to rhSIRT1 is 1.
(D) RhSIRT1 deacetylase activity was determined
by BioMol SIRT1 Fluorimetric Drug Discovery Kit
(BSDK) in the presence or absence of LA-80
(synthetic peptide of carboxyl 80 aa of lamin A).
Data represent mean ± SEM, n = 3. **p < 0.01, LA-
80 + rhSIRT1 versus rhSIRT1 only.
(E) Acetyl FLAG-p53 was incubated with rhSIRT1
in the presence of various amount of LA-80. FLAG-
p53 acetylation was detected by western blotting
with anti-acetyl lysine antibodies (left). Relative
level of acetylated p53 was quantified by ImageJ
(right).
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carboxyl tail (Liu and Zhou, 2008). Although the level of lamin C
was much higher than A in HEK293 cells, lamin C was hardly de-
tected in the anti-SIRT1 immunoprecipitates (Figure 1B), indi-
cating that lamin A likely interacts with SIRT1 via its C-terminal
domain. This notion was further confirmed by coimmunoprecipi-
tation in HEK293 cells expressing FLAG-SIRT1 together with
either lamin A or lamin C. As shown in Figure 1E, lamin A was
detected in the anti-FLAG-SIRT1 immunoprecipitates, whereas
lamin C was negligible. Taken together, these data suggest
that lamin A interacts with SIRT1 through its carboxyl terminus.
Lamin A Is an Activator of SIRT1
The NM association of deacetylase activity suggests the exis-
tence of potential SIRT1 activators on the NM. In mammalian
cells, lysine acetyltransferase p300 and SIRT1 mediate the acet-
ylation and deacetylation of p53 on residue K382 (Gu and
Roeder, 1997). A BioMol SIRT1 Fluorimetric Drug Discovery Kit
(BSDK) utilizes fluorophore-conjugated acetyl p53 peptide to
determine SIRT1 activity. To test the hypothesis, the in vitro de-
acetylase activity of recombinant human SIRT1 (rhSIRT1) deter-
mined byBSDK assaywas quantified in the presence or absence
of NM derived from wild-type cells. The deacetylase activity of
rhSIRT1 was enhanced by approximately 3-fold in the presence
of NM compared with the control without NM (Figure S1D), sug-
gesting potential SIRT1 activator(s) associated with the NM.
These data, together with the fact that lamin A interacts with
SIRT1, prompted us to further examine whether lamin A acts
as an activator of SIRT1. We found that SIRT1 physically inter-
acts with lamin A, as rhSIRT1 was pulled down by recombinant
human lamin A (rhLamin A) in the test tube (Figure 2A). Addition-
ally, in the presence of rhLamin A, the deacetylase activity of740 Cell Metabolism 16, 738–750, December 5, 2012 ª2012 ElsevierrhSIRT1 toward BSDK acetyl p53 peptide was increased in
a lamin A dose-dependent manner (Figure 2B). Lamin A-stimu-
lated SIRT1 deacetylase activity was completely abolished by
SIRT1 inhibitor Suramin Sodium. We also tested the effect of
rhLamin A on the native target of SIRT1, i.e., acetyl p53. Full-
length acetyl FLAG-p53 was purified by anti-FLAG immunopre-
cipitation in HEK293 cells ectopically expressing FLAG-p53
and HA-p300. SIRT1 deacetylation assay was performed as
described in Experimental Procedures. As shown in Figure 2C,
an approximate 40% decrease in the acetylation level of
FLAG-p53 was observed in the presence of rhLamin A-rhSIRT1
complex, compared with rhSIRT1 only. Moreover, the synthetic
peptide (LA-80) containing the carboxyl 80 aa of lamin A protein
increased SIRT1 deacetylase activity in a dose-dependent
manner in either BSDK assay (Figure 2D) or the assay using puri-
fied full-length acetyl p53 protein (Figure 2E). Notably, the activa-
tion of the rhSIRT1 activity by LA-80 was saturated when the
molar ratio between LA-80 and rhSIRT1was close to 1:1 (Figures
2D and 2E). Collectively, these data suggest that lamin A serves
as a SIRT1 activator.
Resveratrol Stimulates SIRT1 Deacetylase Activity in
a Lamin A-Dependent Manner
Resveratrol, a potential SIRT1 activator, has been reported to en-
hance health span in a range of age-related diseases. However,
independent studies have revealed that resveratrol activates
SIRT1 toward the fluorophore-conjugated synthetic p53 peptide
rather than its unconjugated native targets (Borra et al., 2005; Dai
et al., 2010; Kaeberlein et al., 2005; Pacholec et al., 2010).
Consistent with the published data, we also found that resvera-
trol didn’t enhance SIRT1 deacetylase activity toward full-length
acetyl FLAG-p53 (Figure 3A, left panel). Yet remarkably, in theInc.
Figure 3. Resveratrol Activates SIRT1 in
a Lamin A-Dependent Manner
(A) A representative western blot showing FLAG-
p53 acetylation using anti-acetyl lysine antibodies.
Acetyl FLAG-p53 was incubated with rhSIRT1
in the presence or absence of rhLamin A and
resveratrol.
(B) Acetyl FLAG-p53 was incubated with rhSIRT1
and rhLamin A in the presence or absence of re-
sveratrol. FLAG-p53 acetylation was detected by
western blotting with anti-acetyl lysine antibodies.
Relative level of acetylated p53 was quantified by
ImageJ. *The molar ratios of rhLamin A to rhSIRT1
are 0.5, 1.0, and 2.0, respectively.
(C) A representative western blot showing rhSIRT1
pulled down by anti-lamin A/C antibody in the
presence or absence of resveratrol.
(D) A representative western blot showing that
treatment with increasing concentrations of re-
sveratrol resulted in increased interaction between
SIRT1 and lamin A. FLAG- SIRT1 and lamin A
were cotransfected into HEK293 cells. Cells were
treated with resveratrol followed by anti-FLAG
immunoprecipitation before being subjected to
western blotting.
(E) Quantification of (D). Data represent mean ±
SEM, n = 3. *p < 0.05.
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deacetylase activity toward its native target, acetyl p53 (Fig-
ure 3A, right panel). rhLamin A alone enhances rhSIRT1 deace-
tylase activity independent of resveratrol (Figures 3B, left panel),
and resveratrol further enhances the activation of rhSIRT1 de-
acetylase activity mediated by rhLamin A (Figures 3B, right
panel). Further investigation revealed that resveratrol enhanced
the association between rhSIRT1 and rhLamin A both in the
test tube (Figure 3C) and in HEK293 cells examined by coimmu-
noprecipitation (Figures 3D and 3E).
SIRT1 Is Mislocalized in Progeroid Cells
It is widely accepted that the unprocessed C-terminal tail in pro-
gerin or prelamin A is responsible for the progeroid features in
HGPS and progeria mouse models. Given that lamin A interacts
with SIRT1 via its C-terminal domain, we examined whether the
interaction between SIRT1 and prelamin A or progerin is reduced
compared to lamin A. We performed coimmunoprecipitation in
HEK293 cells expressing FLAG-SIRT1 together with one of the
A-type lamins, i.e., wild-type lamin A, or prelamin A or progerin.
As shown in Figures 4A and 4B, significantly less prelamin A and
progerin were pulled down by anti-FLAG antibodies, compared
with lamin A, though comparable or higher levels of prelamin A
and progerin were present in the input. These data suggest
that SIRT1 preferentially interacts with lamin A, whereas prela-
min A or progerin has significantly reduced association with
SIRT1 in cells.Cell Metabolism 16, 738–750,Since lamin A is one of the major com-
ponents of NM, we further investigated
the association of SIRT1 with the NM by
subcellular fractionation. SIRT1/ cells
were utilized as a negative control forthe specific staining of SIRT1 protein. NM-associated KAP-1
(KRAB-associated protein 1) (Goodarzi et al., 2008) and chro-
matin-bound MCM3 (Me´ndez and Stillman, 2000) served as
controls for the purity of the subcellular fractionation. As ex-
pected, KAP-1 was resistant to MNase digestion and remained
in the NM fraction (P20), whereas the majority of MCM3 was
released into the nucleoplasmic and chromatic fraction (S20)
after MNase treatment (Figure S2A). Consistent with its interac-
tion with lamin A, SIRT1 protein was enriched in the NM fraction
(P20) in MEFs (Figure S2B). Since prelamin A has less binding
capacity to SIRT1 compared with lamin A and SIRT1 is highly
expressed in stem cells (Saunders et al., 2010), we examined
SIRT1 localization in Zmpste24/ cells by subcellular fraction-
ation in multipotent BMSCs. NM-associated SIRT1 was largely
reduced in Zmpste24/ BMSCs compared to wild-type con-
trols (Figure 4C, right panel), though total nuclear proportion of
SIRT1 was comparable (Figures 4C, left panel). The reduction
in NM-associated SIRT1 appeared specific, because SIRT6,
CBP acetyltransferase, and Foxo3a were not significantly
affected in Zmpste24/ cells. The NM-associated SIRT1 was
also reduced in HGPS dermal fibroblasts, including HG143,
HG188, HG164, and HG122, compared to either healthy F2-S
fibroblasts or dermal fibroblasts harboring nonprogeria LMNA
mutations, i.e., R453W in Emery Dreifuss Muscular Dystrophy
(EDMD), R482W in Familial Lipodystrophy (FLPD), and R401C
in EDMD (Liu and Zhou, 2008) (Figures S2C and S2D). Though
total nuclear level of SIRT1 was variable in different HGPS cellDecember 5, 2012 ª2012 Elsevier Inc. 741
Figure 4. Mislocalization of SIRT1 in Progeroid Cells
(A) HEK293 cells were transiently transfected with FLAG-SIRT1 together with one of the A-type lamins, i.e., wild-type lamin A, unprocessible prelamin A, and
progerin. Western blotting was performed to determine levels of A-type lamins in anti-FLAG immunoprecipitates. Representative immunoblot shows that
significantly less prelamin A/progerin was pulled down by anti-FLAG antibody compared with wild-type lamin A, even though comparable or higher level of
prelamin A/progerin was found in the inputs.
(B) Quantification of (A). Data represent mean ± SEM, n = 3. **p < 0.01.
(C) A representative immunoblot showing various proteins in nuclear (Nu, P1) and nuclear matrix (NM, P20) fractions in BMSCs. NM-associated SIRT1 was
significantly reduced in Zmpste24/ BMSCs, whereas levels of Sirt6, CBP, Foxo3a, histone H3, and b-actin were comparable between wild-type and
Zmpste24/ BMSCs in NM fraction. Total nuclear level of SIRT1 was not changed.
(D) Quantification of (C). Data represent mean ± SEM, n = 3. **p < 0.01.
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reduced. Moreover, ectopic expression of prelamin A and pro-
gerin caused remarkable disassociation of SIRT1 from the NM,
while the nuclear level of SIRT1 was hardly affected in HEK293
cells (Figures 4E and 4F). Taken together, these observations
suggest that prelamin A or progerin compromises the proper
NM localization of SIRT1.
SIRT1 Deacetylase Activity Is Compromised
in Progeroid Cells
To further assess the functional significance of mislocalization of
SIRT1, we applied BSDK assay to compare the rhSIRT1 activa-
tion by NM prepared from wild-type or Zmpste24/ BMSCs.
Consistently, the deacetylase activity of rhSIRT1 was enhanced
approximately 3-fold in the presence of NM from wild-type
BMSCs (Figure 5A). In contrast, the NM from the Zmpste24/
BMSCs showed a significantly reduced stimulatory effect on
rhSIRT1 deacetylase activity. Cytoplasm did not significantly
enhance rhSIRT1 activity. We next examined downstream path-
way(s) of SIRT1 in progeria cells. SIRT1 deacetylates Foxo3a
and upregulates its transcriptional activity, thus promoting
expression of antioxidant enzymes such as MnSOD and cata-
lase in response to oxidative stress (Brunet et al., 2004). Consis-
tent with the mislocalization of SIRT1 and significantly less acti-
vation of rhSIRT1 in the test tube, Foxo3awas hyperacetylated in
Zmpste24/ BMSCs, and the levels of catalase and Gadd45a
were reduced by approximately 40% in Zmpste24/ mice rela-
tive to wild-type controls (Figures 5B and 5C). The increase in
Foxo3a acetylation is likely the result of decreased SIRT1 deace-
tylase activity in vivo, as neither total nuclear SIRT1 level nor NM
association of CBP, the acetyltransferase for Foxo3a, was
changed in Zmpste24/ BMSCs (Figures 4C and 4D). Support-
ing this idea, ectopic expression of either prelamin A or progerin
increased the acetylation of FOXO3A and reduced the ex-
pression of catalase, MnSOD, and GADD45a in HEK293 cells
(Figures 5D and 5E). Consistent with elevated levels of acetyl
Foxo3a, levels of acetyl FLAG-p53 are also significantly higher
in HEK293 cells ectopically expressing prelamin A and progerin
compared with those expressing wild-type lamin A (Figure 5F).
As SIRT1 interacts with lamin A and thus associates with NM,
and resveratrol increases the binding between lamin A and
SIRT1, we asked whether resveratrol enhances NM association
of SIRT1. As shown in Figures S3A and S3B, in wild-type and
Zmpste24/ BMSCs incubated with different concentrations
of resveratrol, NM-associated SIRT1 was increased compared
to untreated controls. The ability of resveratrol to stimulate the
NM association of SIRT1 was also observed in test tube. When
equal amounts of rhSIRT1 were incubated with the insoluble
NM fraction from either wild-type or Zmpste24/ cells sus-
pended in BSDK assay buffer, significantly less NM-bound
rhSIRT1was found in precipitates from Zmpste24/NM relative
to wild-type NM precipitates in the absence of resveratrol (Fig-
ure 5G). The presence of resveratrol enhanced the associa-
tion of rhSIRT1 with NM derived from both wild-type and(E) Lamin A, unprocessible prelamin A, or progerin was stably expressed in HE
determine the NM-associated SIRT1. A representative western blotting shows t
transfected cells compared with wild-type lamin A, the levels of Foxo3a and b-c
(F) Quantification of (E). Data represent mean ± SEM, n = 3. **p < 0.01.
Cell MZmpste24/ cells. Consistently, rhSIRT1 level in the superna-
tant underwent a compensatory reduction (Figure 5G). Collec-
tively, these data suggest that resveratrol could enhance the
interaction between lamin A and SIRT1 to increase the NM asso-
ciation of SIRT1.
Resveratrol Treatment Rescues ASC Decline
in Zmpste24–/– Mice
As resveratrol enhancesSIRT1deacetylase activity by increasing
its binding to lamin A, we decided to examine the effects of re-
sveratrol treatment on the early senescence in Zmpste24/
MEFs.However, noobviousdifference inb-galactosidaseactivity
was observed between resveratrol-treated and saline-treated
Zmpste24/ MEFs (Figure S4A), and resveratrol did not reduce
the elevated levels of p16Ink4a inZmpste24/MEFs (FigureS4B).
Progerin and prelamin A have been previously linked to
defects in mesenchymal stem cells (MSCs) and in hair follicle
progenitor cells in Zmpste24/ mice (Espada et al., 2008;
Scaffidi and Misteli, 2008). Consistently, the number of BMSCs
was significantly reduced in Zmpste24/ mice compared
with wild-type controls at 4 months of age (Figures S5A).
Zmpste24/ BMSCs in culture showed compromised colony-
formingcapacity (FigureS5B), reducedproliferation (FigureS5C),
and a dramatically increased cellular senescence (Figures S5D).
Similarly, an early decline in mononucleated cells (MNCs) and
hematopoietic stem cells (HSCs, LineageFlt3 Sca-1+cKithigh)
was observed in Zmpste24/ mice (Figures S5E–S5G), such
that by 4 months of age HSC levels fell to less than half of that
of wild-type controls. HSC transplantation experiments showed
that the self-renewal defects were cell-intrinsic (Figure S5H).
As SIRT1 is highly expressed in stem cells and is critical for
maintaining stem cell self-renewal and function, we then tested
the effects of resveratrol on ASCs. Interestingly, resveratrol
enhanced the colony-forming capacity in Zmpste24/ BMSCs
in a dose-dependent manner (Figures 6A and 6B). The treatment
increased the binding of SIRT1 to prelamin A, downregulated
acetylation level of Foxox3a, and upregulated the expression
of Gadd45a and catalase (Figures 6C and 6D). Moreover, the
rescue effect of resveratrol is SIRT1 dependent, as knocking
down SIRT1 attenuated its effect on Zmpste24/ BMSCs
(Figures 6D–6F). Knocking downSIRT1 abolished the stimulating
effect of resveratrol on the expression of Gadd45a and catalase
(Figure 6D). Knockdown of SIRT1 decreased colony-forming
capacity (Figures 6E and 6F), whereas ectopic SIRT1 increased
the colony-forming capacity of Zmpste24/ BMSCs to levels
comparable to that of wild-type BMSCs (Figures 6G and 6H).
These data suggest that BMSC decline in Zmpste24/ mice is
attributable largely to impaired SIRT1 function, which can be
rescued by resveratrol.
Resveratrol Alleviates Progeroid Features and Extends
Life Span in Zmpste24–/– Mice
The SIRT1-dependent rescue of BMSC colony-forming capacity
in vitro prompted us to ask whether resveratrol could rescue theK293 cells. Subcellular fractionation and western blotting were performed to
hat while NM association of SIRT1 was reduced in prelamin A- and progerin-
atenin remained unchanged.
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Figure 5. Compromised Foxo3a and p53 Pathways in Progeroid Cells
(A) RhSIRT1 deacetylase activity was determined in the presence of cytoplasmic or NM fraction. The relative increase in deacetylase activity after addition of
rhSIRT1 to the assay buffer, cytoplasm, or NM was determined and plotted. The NM from wild-type BMSCs potentiated rhSIRT1 deacetylase activity, whereas
the stimulating capacity of NM from Zmpste24/ BMSCs was greatly compromised. Data represent mean ± SEM, n = 3. *p < 0.05.
(B) A representative western blot showing hyperacetylation of Foxo3a in Zmpste24/ BMSCs using anti-acetyl lysine antibodies in anti-Foxo3a immunopre-
cipitates.
(C) Quantification of (B). Data represent mean ± SEM, n = 3. *p < 0.05, **p < 0.01.
(D) Upper: A representative western blot showing acetylation of Foxo3a using anti-acetyl lysine antibodies in anti-Foxo3a immunoprecipitates in HEK293 cells
ectopically expressing lamin A or prelamin A or progerin. Lower: Expression of catalase, MnSOD, and GADD45a in the input.
(E) Quantification of (D). Data represent mean ± SEM, n = 3. *p < 0.05, **p < 0.01.
(F) A representative western blot showing acetylation level of ectopic FLAG-p53 in HEK293 cells transfected with different lamin A in the presence or absence of
resveratrol. Relative level of acetylated FLAG-p53 was quantified by ImageJ.
(G) Resveratrol enhanced the association of rhSIRT1 with NM in test tube. Recombinant hSIRT1 was incubated with NM fraction prepared from wild-type or
Zmpste24/ BMSCs in the presence and absence of resveratrol (10 mM) in a similar way as the SIRT1 deacetylase activity assay was performed. Insoluble NM
and reaction buffer were separated by centrifugation. Western blotting and Coomassie blue staining were performed to determine the level of rhSIRT1.
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Figure 6. Resveratrol Rescues BMSC Decline in Zmpste24–/– Mice in a SIRT1-Dependent Manner
(A) A representative photo showing that resveratrol (10 mM) increased colony-forming capacity of Zmpste24/BMSCs. Colony-forming assay was performed on
freshly isolated bone marrow cells in 10 cm dishes in the presence and absence of resveratrol.
(B) Colony number counting. Data showed that resveratrol (RSV) increased colony-formation capacity of Zmpste24/ BMSCs in a dose-dependent manner
(2 mM and 10 mM). Data represent mean ± SEM, n = 4. *p < 0.05, RSV versus vehicle.
(C) Left: Representative western blot showing level of prelamin A pull-down in Zmpste24/ BMSCs by anti-SIRT1 immunoprecipitates in the presence or
absence of resveratrol (2 mM). Right: Representative western blot showing level of acetylated Foxo3a from the Zmpste24/ BMSCs in the presence or absence
of resveratrol (2 mM).
(D) A representative western blot showing levels of catalase and Gadd45a in SIRT1 or scramble siRNA-treated Zmpste24/ BMSCs in the presence or absence
of resveratrol (10 mM).
(E) A representative photo showing colony-forming capacity of Zmpste24/ BMSCs by SIRT1 or scramble knocking down in the presence or absence of re-
sveratrol. Resveratrol treatment (10 mM) increased the colony-forming capacity in Zmpste24/ BMSCs (left), and this was completely abolished by knocking
down SIRT1 (right). Colony-forming assay was done on freshly isolated cells in 6-well plates.
(F) Quantification of (E). Data represent mean ± SEM, n = 5. *p < 0.05, ‘‘Scramble + RSV’’ versus ‘‘Scramble + Veh.’’
(G) A representative photo showing that ectopic SIRT1 increased the colony-forming capacity of Zmpste24/ and wild-type BMSCs. Colony-forming assay was
performed on freshly isolated cells in 6 cm dishes.
(H) Quantification of (G). Data represent mean ± SEM, n = 5. *p < 0.05, SIRT1 versus Mock.
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Lamin A-Dependent Activation SIRT1 by ResveratrolBMSC defects in Zmpste24/ mice in vivo. To test this, resver-
atrol was supplemented at a concentration of 20 mg/ml in
drinking water. Four months after treatment, BMSCs were
collected for examination and comparison between resvera-
trol-treated and vehicle-treated Zmpste24/ mice. As shown
in Figures 7A and 7B, BMSC colony-forming efficiency was sig-
nificantly increased in the resveratrol-treated group. Concomi-
tantly, resveratrol treatment enhanced the level of catalase
whereas it decreased the level of H3K9ac (a direct target of
SIRT1) in BMSCs (Figure S6). Resveratrol treatment also
rescued the early decline in HSCs (Figure 7C). Moreover, resver-
atrol treatment ameliorated progeroid features in Zmpste24/
mice. As shown by micro-CT analyses, the trabeculae in
Zmpste24/ mice appeared to be thinner and more widely
spaced. Treatment by resveratrol for 4 months increased the
trabecular thickness, improved the structural organization, and
increased bone mineral density (Figures 7D and 7E). In addi-
tion, resveratrol treatment also significantly slowed down the
body weight loss, compared to vehicle-treated controls (Fig-
ures 7F and 7G). Most importantly, the median survival was
extended from 20 weeks in vehicle-treated Zmpste24/ mice
to 27weeks in resveratrol-treatedZmpste24/mice (Figure 7H).
By 26 weeks after birth, 95% of Zmpste24/ mice had died,
whereas nearly 60% of resveratrol-treated animals were still
alive. The maximum life span (mean life span of the longest-lived
10% of the animals) was prolonged from 27.5 weeks in vehicle-
treated to 33.5 weeks in resveratrol-treated Zmpste24/ mice
(Figure 7I).
DISCUSSION
Here we report that lamin A is an endogenous activator of
SIRT1. Compared with lamin A, SIRT1 interacts weakly with
prelamin A or progerin in vivo. Since lamin A interacts with
SIRT1 through its C-terminal domain, the farnesylated carboxyl
tail in prelamin A or progerin might interfere with their binding
to SIRT1 and therefore reduce the NM association of SIRT1.
Alternatively, the decreased NM association of SIRT1 may result
from the altered structure of NM itself due to the presence of
prelamin A or progerin. The NM association may be required
for directing SIRT1 to specific targets on NM.
Our study reveals amechanism bywhich resveratrol enhances
SIRT1 activity. It has been under hot debate whether resveratrol
directly activates SIRT1 (Villalba et al., 2012). Increasing evi-
dence shows that resveratrol increases the binding of SIRT1
to the fluorophore-conjugated synthetic peptide (Ac-Arg-His-
Lys- Lys(Ac)-AMC) instead of its native targets, e.g., full-length
acetyl p53 and acetyl PGC-1a (Beher et al., 2009; Borra et al.,
2005; Dai et al., 2010; Kaeberlein et al., 2005; Pacholec et al.,
2010). It was proposed that resveratrol indirectly activates
SIRT1 or serves as synergistic factor(s) of endogenous SIRT1
deacetylase activator(s). Consistent with previous reports, we
found that resveratrol alone does not activate SIRT1 toward its
native target acetyl p53. Instead, resveratrol enhances the
binding of SIRT1 to A-type lamins and increases SIRT1 deacety-
lase activity. It is, however, not clear whether this property is
specific to lamin A or can be applied to other in vivo SIRT1 acti-
vators, such as AROS (Kim et al., 2007) or inhibitors, e.g., DBC1
(Kim et al., 2008; Zhao et al., 2008), andwhether other resveratrol746 Cell Metabolism 16, 738–750, December 5, 2012 ª2012 Elseviermimics also activate SIRT1 in a similar manner. Similar to wild-
type lamin A, in the presence of resveratrol, the binding capacity
of prelamin A to SIRT1 was also enhanced. How resveratrol
cooperates with A-type lamins to activate SIRT1 is largely
unclear and relies on the understanding of SIRT1 protein struc-
ture. One possibility is that resveratrol might modulate the
SIRT1 conformation, thus increasing the interaction between
SIRT1 and the carboxyl terminus of A-type lamins and enhancing
the deacetylase activity. Another explanation is that resveratrol
might bridge new interaction between domains of A-type lamins
and SIRT1, and A-type lamins might serve as an allosteric
effector of SIRT1. Interestingly, the last 80 aa on the C terminus
of lamin A exhibit higher potential in activating SIRT1. Therefore it
is also plausible to speculate that the remaining part of lamin A
may impose a conformational barrier for SIRT1 activation,
and resveratrol might lead to allosteric changes in the lamin
A-SIRT1 complex and further activate SIRT1.
Although many of the in vivo benefits of resveratrol are SIRT1
dependent (Baur, 2010), emerging evidence indicates that it
also activates AMPK-independent of SIRT1 (Canto´ et al., 2009;
Gledhill et al., 2007; Hawley et al., 2010; Park et al., 2012). Low
dosage of resveratrol (%25 mM) activates AMPK in a SIRT1-
dependent manner, while high dosage (R50 mM) activates
AMPK independent of SIRT1 (Price et al., 2012). In the current
study, we used low doses (2–10 mM) of resveratrol and did not
observe obvious activation of AMPK; therefore, it is most likely
that the beneficial effects of resveratrol on BMSCs are primarily
attributable to the activation of SIRT1.
SIRT1 is critical for the self-renewal of BMSCs. Knocking
down SIRT1 significantly reduces the colony-forming capacity
in BMSCs, suggesting that stem cell decline in progeroid mice
is attributable, to a large extent, to the compromised function
of SIRT1 due to the presence of prelamin A. Resveratrol rescues
SIRT1-dependent BMSC decline, ameliorates progeroid pheno-
types, and extends the life span of Zmpste24/ mice. Since
resveratrol enhances colony-forming capacity in both wild-type
and Zmpste24/BMSCs (Figures S6A and S6B) and resveratrol
may activate SIRT1 independent of the existing interacting
domains, we cannot exclude the possibility that the effects of
resveratrol in progeroid cells are a bypass function. Interestingly,
resveratrol does not rescue cellular senescence in Zmpste24/
MEFs, suggesting that resveratrol treatment may affect somatic
cells and ASCs differently. As the effects of resveratrol are
pleiotropic (Harikumar and Aggarwal, 2008) and involve both
sirtuin-dependent and independent pathways, it seems that
resveratrol influences sirtuin and nonsirtuin pathways differently
in ASCs and somatic cells. Given the fact that SIRT1 is highly ex-
pressed in stem cells compared to somatic cells (Saunders et al.,
2010), the different effects of resveratrol on BMSCs and MEFs
may also lie in the difference in level of SIRT1 expression.
Although there is no direct evidence to link the life span exten-
sion to stem cell rescue, it is conceivable that stem cell rescue
by resveratrol treatment in Zmpste24/ mice contributes, at
least in part, to the amelioration of progeroid phenotypes, given
the fact that resveratrol does not significantly rescue senes-
cence in somatic cells. Since SIRT1 affects multiple pathways
(Lavu et al., 2008; Smith et al., 2008), it is not clear which down-
stream targets of SIRT1 influence the maintenance of BMSCs
in Zmpste24/ mice. However, Foxo3a-mediated oxidativeInc.
Figure 7. Resveratrol Rescues ASC Decline, Ameliorates Progeroid Features, and Extends Life Span in Zmpste24–/– Mice
(A) Colony-forming capacity of BMSCs in Zmpste24/ mice treated with either vehicle or resveratrol (20 mg/ml in drinking water). Colony-forming assays were
performed on freshly isolated bone marrow cells in 10 cm dishes.
(B) Quantification of (A). Data represent average colony number of BMSCs ± SEM, n = 3. *p < 0.05.
(C) Feeding Zmpste24/ mice with resveratrol increased HSC population. Each dot represents the percentage of HSC population in total bone marrow
mononucleated cells in an individual mouse. *p < 0.05, vehicle-treated Zmpste24/ mice versus wild-type and resveratrol-treated (20 mg/ml in drinking water)
versus vehicle-treated Zmpste24/ mice.
(D) Micro-CT examination of trabecular bone structure in wild-type mice and in Zmpste24/ mice treated with either resveratrol (20 mg/ml in drinking water) or
vehicle.
(E) Resveratrol treatment increased bone mineral density in Zmpste24/mice. Data represent mean ± SEM, n = 3. *p < 0.05, vehicle-treated Zmpste24/mice
versus wild-type and resveratrol-treated (20 mg/ml in drinking water) versus vehicle-treated Zmpste24/ mice.
(F) Body weight in resveratrol-treated and vehicle-treated male Zmpste24/ mice. Data represent mean ± SEM, n = 10. *p < 0.05.
(G) Body weight in resveratrol-treated and vehicle-treated female Zmpste24/ mice. Data represent mean ± SEM, n = 10. *p < 0.05.
(H) Survival rate in resveratrol-treated and vehicle-treated Zmpste24/ mice. p < 0.0001.
(I) Maximal life span in resveratrol-treated and vehicle-treated Zmpste24/ mice. Data represent mean ± SEM. **p < 0.01.
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directly scavenging ROS level via N-acetyl cysteine (NAC)
rescued the decline in BMSCs and HSCs and extended life
span to a similar extent as resveratrol did (Figure S7). Although
life span extension in C. elegans and Drosophila by ectopic Sir2Cell Mwas recently called into question, SIRT1 deficiency in mammals
may affect metabolic and transcriptional adaptation essential for
life in response to stress (Burnett et al., 2011; Chalkiadaki and
Guarente, 2012; Houtkooper et al., 2012; Lombard et al., 2011;
Viswanathan and Guarente, 2011). In this regard, it should beetabolism 16, 738–750, December 5, 2012 ª2012 Elsevier Inc. 747
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atrol may be the consequence of elevated SIRT1-dependent
physiological and metabolic functions necessary for health
span that are severely compromised in Zmpste24/mice. Sup-
porting this idea is the finding that resveratrol prolongs life span
and delays aging-related phenotypes in a short-lived fish strain
(Valenzano et al., 2006). Our data provide amechanistic explana-
tion to stem cell depletion in progeroid syndrome and, impor-
tantly, suggest a therapeutic strategy based on SIRT1 pathway
for HGPS.
EXPERIMENTAL PROCEDURES
Cell Lines, Constructs, Recombinant Proteins, Peptides, and
Antibodies
Cell line, construct, recombinant protein, peptide, and antibody information
can be found in the Supplemental Information.
Resveratrol Treatment of Zmpste24–/– Mice
Zmpste24/ mice have been described elsewhere (Penda´s et al., 2002).
Mouse experimentation was performed in accordance with the guidelines of
the Committee on the Use of Live Animals in Teaching andResearch (CULATR)
at the University of Hong Kong. Newborn Zmpste24/ mice and wild-type
controls were fed with resveratrol (20 mg/ml) or NAC (1 mg/ml) in drinking
water. The survival of resveratrol-treated, NAC-treated, or vehicle-treated
Zmpste24/ mice was recorded, and their body weight was monitored
weekly. The trabecular bone organization and bone mineral density were
determined by micro-CT. The survival rate was analyzed by Kaplan-Meier
method, and statistical comparison was performed by Log-rank (Mantel-
Cox) Test.
Bone Marrow Stromal Cells and Hematopoietic Stem Cells
Bone marrow stromal cell and hematopoietic stem cell methodologies can be
found in the Supplemental Information.
Immunofluorescence Staining
BMSCs were grown on chamber slides, followed by fixation and overnight
blocking at 4C. Detailed immunofluorescence staining procedures can be
found in the Supplemental Information.
Protein Extraction, Fractionation, Western Blotting, and
Coimmunoprecipitation
Cells were fractionated as described (Me´ndez and Stillman, 2000). Detailed
procedures for protein extraction, fractionation, western blotting, and coim-
munoprecipitation can be found in the Supplemental Information.
In Vitro SIRT1 Deacetylation Assay
SIRT1 deacetylation assay on fluorophore-conjugated synthetic p53 peptide
was performed with SIRT1 Fluorimetric Drug Discovery Kit (BioMol, Hamburg,
Germany) following the manufacturer’s instructions. Briefly, cells were
fractionated as described above except that protease inhibitors were not
included, and the nuclear matrix fraction was suspended in assay buffer
provided by the supplier. Various cell fractions, recombinant human lamin A
(rhLamin A, Diatheva, Italy), or LA-80 peptide (GL Biochem Ltd., Shanghai,
China) were added in the reaction mix of SIRT1 Fluorimetric Drug Discovery
Kit and incubated for 20 min at 37C, and then the reaction was stopped
and fluorescent signal was detected. SIRT1 deacetylase activity on its native
target was assayed using SIRT1 assay kit from Sigma. Constructs encoding
FLAG-p53 and HA-p300 were cotransfected into HEK293 cells; FLAG-p53
was immunoprecipitated by anti-FLAG M2 Agarose (Sigma) followed by
elution with FLAG peptide (Sigma). Purified acetyl FLAG-p53 was incubated
with recombinant human SIRT1 (rhSIRT1) and NAD+ for 30 min at 37C in
the presence or absence of rhLamin A or resveratrol. The acetylation level
of FLAG-p53 was determined by western blotting with pan-anti-acetyl lysine
antibodies.748 Cell Metabolism 16, 738–750, December 5, 2012 ª2012 ElsevierStatistical Analysis
Statistical significance was accessed by two-tailed t tests. Error bar repre-
sents standard error of the mean (SEM).
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.cmet.2012.11.007.
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